Solid Tumors Refractory to Standard Therapy
4 clinical trials · Condition
◉ Watch Solid Tumors Refractory to Standard Therapy
| Record | Firm | Date |
|---|---|---|
| Interventional Study to Evaluate the Combination of Palbociclib + Sunitinib as a Treatment for Advanced Solid Tumors (NCT06940349) | Rabin Medical Center | 2021-10-21 |
| Kanglaite Injection Phase I Study (NCT00031031) | KangLaiTe USA | 2001-06-01 |
Track Solid Tumors Refractory to Standard Therapy automatically
Every clearance here is in the API, with alerts when new ones post.